Skip to content

A clinical trial protocol to evaluate the efficacy and safety of endoscopic surgical system-assisted laparoscopic total nephroureterectomy

A clinical trial protocol to evaluate the efficacy and safety of endoscopic surgical system-assisted laparoscopic total nephroureterectomy

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200056672
Enrollment
Unknown
Registered
2022-02-10
Start date
2022-02-24
Completion date
Unknown
Last updated
2023-09-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

upper urinary tract urothelial carcinoma

Interventions

Sponsors

Beijing Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Patients with upper urinary tract urothelial carcinoma who need total nephroureterectomy; 2. 18-85 years old, regardless of gender; 3. Tumor stage = T3N0M0; 4. Those who agree to sign the informed consent form and can follow doctor's advice and accept regular follow-up.

Exclusion criteria

Exclusion criteria: 1. History of ipsilateral upper abdominal surgery; 2. Those with severe uncontrolled disease or acute infection; 3. Patients with cardiovascular and cerebrovascular diseases, blood system diseases or diabetes that cannot be controlled and can not achieve the standard of surgery; 4. Those with immune system diseases that cannot be controlled and cannot achieve the surgical standards; 5. Participate in clinical trials of other investigational drugs or devices that have not been completed.

Design outcomes

Primary

MeasureTime frame
successful operation;

Secondary

MeasureTime frame
manipulator operation time;

Countries

China

Contacts

Public ContactLiu Ming

Beijing Hospital

liuming19731029@163.com+86 13911036970

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 6, 2026